Lead Product(s) : Cannabidiol
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Cannassure Therapeutics
Deal Size : $0.4 million
Deal Type : Licensing Agreement
Details : Under the agreement, Cannassure has the exclusive right to use Lipidor’s proprietary drug delivery technology AKVANO®in medicinal cannabis products for the treatment of selected indications such as psoriasis, atopic dermatitis, pain and lesions.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
January 18, 2021
Lead Product(s) : Cannabidiol
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Cannassure Therapeutics
Deal Size : $0.4 million
Deal Type : Licensing Agreement